טוען...
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist
[Image: see text] We report the identification of 13 (INCB3284) as a potent human CCR2 (hCCR2) antagonist. INCB3284 exhibited an IC(50) of 3.7 nM in antagonism of monocyte chemoattractant protein-1 binding to hCCR2, an IC(50) of 4.7 nM in antagonism of chemotaxis activity, an IC(50) of 84 μM in inhi...
שמור ב:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Chemical Society
2011
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4018154/ https://ncbi.nlm.nih.gov/pubmed/24900329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml200030q |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|